Phibro Animal Health Return on Equity

Phibro Animal Health (PAHC) currently reports a ROE of 26.32%. That is above the Healthcare sector average of 22.76%. Use the charts on this page to explore Phibro Animal Health's ROE history and peer comparisons.

Phibro Animal Health's ROE of 26.32% is higher than the Healthcare sector average of 22.76%. That is roughly 15.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Phibro Animal Health's current 26.32% should be judged against Healthcare norms (sector average: 22.76%) and against PAHC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 26.32%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.76%. From there, open related valuation or income-statement pages for Phibro Animal Health, and consider following PAHC for alerts when major investors trade the stock.

Phibro Animal Health is classified in the Healthcare sector. On ROE, it currently shows 26.32% versus a sector average near 22.76%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PAHC with unrelated industries.